ANI Pharmaceuticals (ANIP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on ANI Pharmaceuticals (ANIP) is Neutral.

The composite score behind that read is +0.03, weighing +0.32 of bullish evidence against -0.30 bearish.

ANI Pharmaceuticals last closed at $73.89, +2.65% on the session.

Against the IVW growth benchmark the position is +1.85% over the forecast window.

The read is built from 15 underlying insights — 7 bullish and 8 bearish.

Agreement across those insights is 53%.

12 graded predictions for ANIP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks ANI Pharmaceuticals in the 60th percentile on valuation and the 79th percentile on return on equity, where 100 is best.

ANI Pharmaceuticals is classified under Health Care / Pharmaceuticals, with a market capitalisation of $1.65B.

StockMap tracks ANI Pharmaceuticals as the 47th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite ANI Pharmaceuticals ranks 47th of 151 in the group, against a group median of -0.08.